1. 1. COVID-19 Map. https://coronavirus.jhu.edu/map.html (accessed April 6, 2020).
2. 2. National Health Commission. Interpretation of the Sixth Edition of the Guidance for COVID-19: Prevention, Control, Diagnosis, and Management. http://www.nhc.gov.cn/xcs/fkdt/202002/54e1ad5c2aac45c19eb541799bf637e9.shtml (accessed April 2, 2020). (in Chinese)
3. 3. Lenzer J. Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence. BMJ. 2020; 369:m1335.
4. 4. COVID-19: chloroquine and hydroxychloroquine only to be used in clinical trials or emergency use programmes. European Medicines Agency. https://www.ema.europa.eu/en/documents/press-release/covid-19-chloroquine-hydroxychloroquine-only-be-used-clinical-trials-emergency-use-programmes_en.pdf (accessed April 6, 2020).
5. 5. The Multicenter Collaboration Group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for Chloroquine in the Treatment of Novel Coronavirus Pneumonia. Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 2020; 43:E019. (in Chinese)